SPC352

Remimasólam eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    20.9.2021
  • Application published:
    15.10.2021
  • Grant published:
    15.7.2023
  • Max expiry date:
    28.3.2036
  • Medicine name:
    Byfavo
  • Medicine for children:
    No

Timeline

Today
20.9.2021Application
15.10.2021Publication
15.7.2023Registration
28.3.2036Expires

Marketing license

  • IS authorization number:
    EU/1/20/1505/001
  • Date:
    26.4.2021
  • Foreign authorization number:
    EU/1/20/1505
  • Date:
    26.3.2021

Owner

  • Name:
    Paion UK Limited
  • Address:
    Kew Road 5, Parkshot House, Unit 302, Richmond, London GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents